PLx Pharma Winddown Corp. Quarterly Nonoperating Income (Expense) in USD from Q2 2016 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
PLx Pharma Winddown Corp. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2016 to Q3 2022.
  • PLx Pharma Winddown Corp. Nonoperating Income (Expense) for the quarter ending September 30, 2022 was $2.34M.
  • PLx Pharma Winddown Corp. Nonoperating Income (Expense) for the twelve months ending September 30, 2022 was $36.8M.
  • PLx Pharma Winddown Corp. annual Nonoperating Income (Expense) for 2021 was -$5.34M, a 205% decline from 2020.
  • PLx Pharma Winddown Corp. annual Nonoperating Income (Expense) for 2020 was -$1.75M, a 72.2% increase from 2019.
  • PLx Pharma Winddown Corp. annual Nonoperating Income (Expense) for 2019 was -$6.3M, a 153% decline from 2018.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $36.8M $2.34M +$14.1M Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $22.7M $2.68M +$12.7M Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $10M $7.41M +$15.4M Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-13
Q4 2021 -$5.34M $24.4M +$28.7M Oct 1, 2021 Dec 31, 2021 10-K 2022-03-11
Q3 2021 -$34M -$11.8M -$11.8M -19147% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$22.2M -$10M -$8M -395% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$14.2M -$7.95M -$12.4M -277% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 -$1.75M -$4.29M -$6.05M -344% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 $4.3M $61.8K -$5.32M -98.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $9.61M -$2.02M +$3.47M +63.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $6.14M $4.5M +$12.4M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$6.3M $1.76M -$3.71M -67.9% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-12
Q3 2019 -$2.59M $5.38M +$6M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 -$8.59M -$5.5M -$4.29M -356% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$4.3M -$7.94M -$16.2M -197% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 $11.9M $5.47M +$7.04M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-13
Q3 2018 $4.81M -$622K -$740K -628% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $5.55M -$1.21M -$2.32M -208% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $7.88M $8.22M +$8.3M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$419K -$1.57M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-08
Q3 2017 $118K +$147K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $1.12M +$1.14M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 -$81.6K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q3 2016 -$28.8K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$24.3K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.